| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8452586 | Experimental Hematology | 2018 | 23 Pages |
Abstract
- Intrinsic and extrinsic bone morphogenic protein (BMP) signaling alterations promote cancer stem cell (CSC) features.
- Under treatment, BMP alterations evolve independently of the oncogene.
- Leukemic and nonleukemic BMP deregulations drive resistance and constitute therapeutic targets.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Florence Zylbersztejn, Mario Flores-Violante, Thibault Voeltzel, Franck-Emmanuel Nicolini, Sylvain Lefort, Véronique Maguer-Satta,